Leor Sapir is a fellow at the Manhattan Institute focusing on Gender in American policy at the state and federal level. In this calmvo we discuss how special interests groups interact with the courts to shape public values, and how the gender issue won't be solved without serious longterm strategy. Follow Leor at https://twitter.com/LeorSapir Find Leor at https://manhattan.institute/person/leor-sapir Support this channel:  https://www.paypal.me/benjaminboyce https://cash.app/$benjaminaboyce https://www.buymeacoffee.com/benjaminaboyce

Leor Sapir, an expert in gender-affirming care, joins Sasha and Stella to discuss the consumerism of gender-affirming care, bans on gender-affirming care in the US, fostering of narcissism, and parallels with the recovered memory craze from the 1990s.

Leor Sapir, a writer and researcher at the Manhattan Institute and frequent contributor to City Journal, discusses topics such as the sudden increase in girls seeking transition, the medicalization of trans kids impacting their future orgasms, childhood experiences living on a kibbutz in Israel, serving in the IDF, the Dutch protocol for transing gender-dysphoric kids, and the shifting rhetoric surrounding gender identity.

Leor Sapir, a Fellow at the Manhattan Institute and expert in constitutional law, dives into the legal landscape of child gender medicine. He discusses the ongoing Supreme Court case regarding child transitions, revealing how the definition of 'rights' has transformed U.S. culture. Sapir examines crucial legal challenges, the implications of the Scrimetti case, and the complexities surrounding child abuse definitions in gender policy. His insights on the evolving relationship between law, medicine, and societal expectations shed light on the contentious debates shaping today’s discourse.

Leor Sapir discusses the Biden administration's gender medicine policies, Title IX redefinition, and lack of scientific evidence in advocating for pediatric gender affirming care. The episode delves into the challenges faced in balancing politics and evidence-based policies, legal risks in federally funded education programs, and the role of state and federal levels in shaping gender medicine regulations.